Google the difference between a sponsored trial and a investigator lead research. The cost and man power needed on the sponsor side (rap) is significantly different for both. I also note that if this is real world data collection, then there doesn’t need to be much resources compared to a full fledged clinical trial. It’s very clear this is not a similar trial to what we saw in the US, you see that don’t you? This is nothing to do with efficacy of the product..
- Forums
- ASX - By Stock
- RAP
- Ann: ResApp Builds European Market Presence
Ann: ResApp Builds European Market Presence, page-58
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 206 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online